Lidocaine Hydrochloride Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Lidocaine Hydrochloride Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Feb 22, 2012.

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-4776-01
Dosage Form
Injection
Presentation
Lidocaine Hydrochloride Preservative Free, Injection, 300 mg/20 mL (1.5%; 15 mg/mL) (NDC 0409-4776-01)
Initial Posting
Feb 22, 2012

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.